» Articles » PMID: 28747511

Autologous Minced Muscle Grafts Improve Endogenous Fracture Healing and Muscle Strength After Musculoskeletal Trauma

Overview
Journal Physiol Rep
Specialty Physiology
Date 2017 Jul 28
PMID 28747511
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The deleterious impact of concomitant muscle injury on fracture healing and limb function is commonly considered part of the natural sequela of orthopedic trauma. Recent reports suggest that heightened inflammation in the surrounding traumatized musculature is a primary determinant of fracture healing. Relatedly, there are emerging potential therapeutic approaches for severe muscle trauma (e.g., volumetric muscle loss [VML] injury), such as autologous minced muscle grafts (1 mm pieces of muscle; GRAFT), that can partially prevent chronic functional deficits and appear to have an immunomodulatory effect within VML injured muscle. The primary goal of this study was to determine if repair of VML injury with GRAFT rescues impaired fracture healing and improves the strength of the traumatized muscle in a male Lewis rat model of tibia open fracture. The most salient findings of the study were: (1) tibialis anterior (TA) muscle repair with GRAFT improved endogenous healing of fractured tibia and improved the functional outcome of muscle regeneration; (2) GRAFT repair attenuated the monocyte/macrophage (CD45CDllb) and T lymphocyte (CD3) response to VML injury; (3) TA muscle protein concentrations of MCP1, IL-10, and IGF-1 were augmented in a proregenerative manner by GRAFT repair; (4) VML injury concomitant with osteotomy induced a heightened systemic presence of alarmins (e.g., soluble RAGE) and leukocytes (e.g., monocytes), and depressed IGF-1 concentration, which GRAFT repair ameliorated. Collectively, these data indicate that repair of VML injury with a regenerative therapy can modulate the inflammatory and regenerative phenotype of the treated muscle and in association improve musculoskeletal healing.

Citing Articles

Age-associated functional healing of musculoskeletal trauma through regenerative engineering and rehabilitation.

Habing K, Alcazar C, Duke V, Tan Y, Willett N, Nakayama K Biomater Sci. 2024; 12(20):5186-5202.

PMID: 39172120 PMC: 11698469. DOI: 10.1039/d4bm00616j.


Multiprotein collagen/keratin hydrogel promoted myogenesis and angiogenesis of injured skeletal muscles in a mouse model.

Namjoo A, Hassani A, Amini H, Nazaryabrbekoh F, Saghati S, Saadatlou M BMC Biotechnol. 2024; 24(1):23.

PMID: 38671404 PMC: 11055224. DOI: 10.1186/s12896-024-00847-4.


The local and systemic effects of immune function on fracture healing.

Evans A, Giannoudis P, Leucht P, McKinley T, Gaski G, Frey K OTA Int. 2024; 7(2 Suppl):e328.

PMID: 38487403 PMC: 10936162. DOI: 10.1097/OI9.0000000000000328.


Local IL-10 delivery modulates the immune response and enhances repair of volumetric muscle loss muscle injury.

Huynh T, Reed C, Blackwell Z, Phelps P, Herrera L, Almodovar J Sci Rep. 2023; 13(1):1983.

PMID: 36737628 PMC: 9898301. DOI: 10.1038/s41598-023-27981-x.


FK506 increases susceptibility to musculoskeletal infection in a rodent model.

Shiels S, Muire P, Wenke J BMC Musculoskelet Disord. 2022; 23(1):716.

PMID: 35897089 PMC: 9327275. DOI: 10.1186/s12891-022-05667-1.


References
1.
Corona B, Wenke J, Ward C . Pathophysiology of Volumetric Muscle Loss Injury. Cells Tissues Organs. 2016; 202(3-4):180-188. DOI: 10.1159/000443925. View

2.
Abou-Khalil R, Yang F, Lieu S, Julien A, Perry J, Pereira C . Role of muscle stem cells during skeletal regeneration. Stem Cells. 2015; 33(5):1501-11. DOI: 10.1002/stem.1945. View

3.
Allen J, Wynn T . Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog. 2011; 7(5):e1002003. PMC: 3093361. DOI: 10.1371/journal.ppat.1002003. View

4.
Meinel L, Zoidis E, Zapf J, Hassa P, Hottiger M, Auer J . Localized insulin-like growth factor I delivery to enhance new bone formation. Bone. 2003; 33(4):660-72. DOI: 10.1016/s8756-3282(03)00207-2. View

5.
Katakura T, Miyazaki M, Kobayashi M, Herndon D, Suzuki F . CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J Immunol. 2004; 172(3):1407-13. DOI: 10.4049/jimmunol.172.3.1407. View